Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathis

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
Frontiers in Oncology|January 10, 2022
Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case StudyHaruna Nonaka, Shuya Kandori, Satoshi Nitta, et al.
Scientific Reports|August 21, 2025
A novel, synthesized, amphiphilic ethylene glycol squalene derivative suppresses BBN-induced bladder carcinogenesisKeisuke Sano, Masanobu Shiga, Farhana Ferdousi, et al.
Oncology Reports|November 29, 2021
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinomaKen Tanaka, Shuya Kandori, Shotaro Sakka, et al.
Cancer Research Communications|September 5, 2025
Prognostic impact of immune-related adverse events on combination immune checkpoint/tyrosine kinase inhibition for metastatic renal cancerBunpei Isoda, Masanobu Shiga, Shuya Kandori, et al.
Scientific Reports|April 23, 2026
Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumabSatoka Kinase, Yoshiyuki Nagumo, Bunpei Isoda, et al.
BMJ Open|December 12, 2025
Triple-drug therapy with Goreisan, tranexamic acid and carbazochrome sodium sulfonate hydrate to prevent recurrence after chronic subdural haematoma surgery: a multicentre, randomised, controlled trial protocolHaruka Negishi, Koji Hirata, Hitoshi Aiyama, et al.
Pharmaceutics|September 28, 2021
Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant TumorsAlexander Zaboronok, Sergey Taskaev, Olga Volkova, et al.
BMC Cancer|March 14, 2025
Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in JapanShuhei Suzuki, Yoshiyuki Nagumo, Kosuke Kojo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2022
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumorsTakashi Kawahara, Koji Kawai, Takahiro Kojima, et al.
The Journal of Biological Chemistry|November 10, 2007
High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)Huey-Sheng Shieh, Karl J Mathis, Jennifer M Williams, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Frontiers in Oncology|January 10, 2022
Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case StudyHaruna Nonaka, Shuya Kandori, Satoshi Nitta, et al.
Scientific Reports|August 21, 2025
A novel, synthesized, amphiphilic ethylene glycol squalene derivative suppresses BBN-induced bladder carcinogenesisKeisuke Sano, Masanobu Shiga, Farhana Ferdousi, et al.
Oncology Reports|November 29, 2021
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinomaKen Tanaka, Shuya Kandori, Shotaro Sakka, et al.
Cancer Research Communications|September 5, 2025
Prognostic impact of immune-related adverse events on combination immune checkpoint/tyrosine kinase inhibition for metastatic renal cancerBunpei Isoda, Masanobu Shiga, Shuya Kandori, et al.
Scientific Reports|April 23, 2026
Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumabSatoka Kinase, Yoshiyuki Nagumo, Bunpei Isoda, et al.
BMJ Open|December 12, 2025
Triple-drug therapy with Goreisan, tranexamic acid and carbazochrome sodium sulfonate hydrate to prevent recurrence after chronic subdural haematoma surgery: a multicentre, randomised, controlled trial protocolHaruka Negishi, Koji Hirata, Hitoshi Aiyama, et al.
Pharmaceutics|September 28, 2021
Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant TumorsAlexander Zaboronok, Sergey Taskaev, Olga Volkova, et al.
BMC Cancer|March 14, 2025
Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in JapanShuhei Suzuki, Yoshiyuki Nagumo, Kosuke Kojo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2022
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumorsTakashi Kawahara, Koji Kawai, Takahiro Kojima, et al.
The Journal of Biological Chemistry|November 10, 2007
High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)Huey-Sheng Shieh, Karl J Mathis, Jennifer M Williams, et al.
Pageof 28